Laura A. Puzniak, MPH, PhD

Global Director, Outcomes Research
Merck & Co

Disclosure(s): Merck & Co., Inc.: former employee and stockholder

Poster(s):

• 673 - Study of Prescribing patterns and Effectiveness of Ceftolozane/Tazobactam Real-world Analysis (SPECTRA): Results from a multi-national, multicenter observational study
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET